Quest Partners LLC Capricor Therapeutics, Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 6,809 shares of CAPR stock, worth $67,341. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,809
Previous 5,676
19.96%
Holding current value
$67,341
Previous $78.3 Million
17.51%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CAPR
# of Institutions
141Shares Held
17.2MCall Options Held
1.51MPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA2.26MShares$22.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$22.3 Million0.12% of portfolio
-
State Street Corp Boston, MA1.84MShares$18.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$16.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA901KShares$8.91 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $241M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...